Atlas Trials

Safety & Immunogenicity Study of Ad5 Based Oral Norovirus Vaccines

Clinical trial NCT03897309 · COMPLETED

Trial details

NCT number
NCT03897309
Sponsor
Vaxart
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Norovirus Infection
Start date
2019-03-20
Primary completion
2021-01-15
Enrollment
86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.